111 related articles for article (PubMed ID: 3885764)
1. Effect of tranquilizers on borderline and schizotypal patients questioned.
Rockland LH
Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
[No Abstract] [Full Text] [Related]
2. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
Serban G; Siegel S
Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for patients with borderline personality disorder.
Gunderson JG
Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
[No Abstract] [Full Text] [Related]
4. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.
Goldberg SC; Schulz SC; Schulz PM; Resnick RJ; Hamer RM; Friedel RO
Arch Gen Psychiatry; 1986 Jul; 43(7):680-6. PubMed ID: 3521531
[TBL] [Abstract][Full Text] [Related]
5. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.
Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM
Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532
[TBL] [Abstract][Full Text] [Related]
6. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.
Soloff PH; George A; Nathan S; Schulz PM; Cornelius JR; Herring J; Perel JM
J Clin Psychopharmacol; 1989 Aug; 9(4):238-46. PubMed ID: 2768542
[TBL] [Abstract][Full Text] [Related]
7. An open, noncomparative study of amoxapine in borderline disorders.
Jensen HV; Andersen J
Acta Psychiatr Scand; 1989 Jan; 79(1):89-93. PubMed ID: 2648768
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine in the treatment of borderline and schizotypal personality disorders.
Markovitz PJ; Calabrese JR; Schulz SC; Meltzer HY
Am J Psychiatry; 1991 Aug; 148(8):1064-7. PubMed ID: 1853957
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment of the personality disorders.
Stein G
Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689
[TBL] [Abstract][Full Text] [Related]
10. The use of low-dose neuroleptics in the treatment of "schizo-obsessive" patients.
Schulz SC
Am J Psychiatry; 1986 Oct; 143(10):1318-9. PubMed ID: 2876650
[No Abstract] [Full Text] [Related]
11. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states].
Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985
[TBL] [Abstract][Full Text] [Related]
12. Stelazine advertisement "dismays" readers.
Swartz M; Taska R; Hargett A; Noll B; Fraker W
Am J Psychiatry; 1985 May; 142(5):666. PubMed ID: 3985219
[No Abstract] [Full Text] [Related]
13. Familial transmission of schizotypal and borderline personality disorders.
Baron M; Gruen R; Asnis L; Lord S
Am J Psychiatry; 1985 Aug; 142(8):927-34. PubMed ID: 4025588
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical effects of amitriptyline on borderline patients.
Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
Am J Psychiatry; 1986 Dec; 143(12):1603-5. PubMed ID: 3538914
[TBL] [Abstract][Full Text] [Related]
15. Treatment utilization by patients with personality disorders.
Bender DS; Dolan RT; Skodol AE; Sanislow CA; Dyck IR; McGlashan TH; Shea MT; Zanarini MC; Oldham JM; Gunderson JG
Am J Psychiatry; 2001 Feb; 158(2):295-302. PubMed ID: 11156814
[TBL] [Abstract][Full Text] [Related]
16. A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics.
Garbutt JC; Loosen PT
Psychoneuroendocrinology; 1984; 9(3):311-4. PubMed ID: 6436858
[TBL] [Abstract][Full Text] [Related]
17. Schizotypal symptoms in patients with borderline personality disorders.
George A; Soloff PH
Am J Psychiatry; 1986 Feb; 143(2):212-5. PubMed ID: 3946657
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria for the borderline and schizotypal personality disorders.
Widiger TA; Frances A; Warner L; Bluhm C
J Abnorm Psychol; 1986 Feb; 95(1):43-51. PubMed ID: 3700846
[No Abstract] [Full Text] [Related]
19. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.
Coccaro EF
J Clin Psychiatry; 1998; 59 Suppl 1():30-5; discussion 36-7. PubMed ID: 9448667
[TBL] [Abstract][Full Text] [Related]
20. The impact of borderline and schizotypal personality disorders on patients and their families.
Schulz PM; Schulz SC; Hamer R; Resnick RJ; Friedel RO; Goldberg SC
Hosp Community Psychiatry; 1985 Aug; 36(8):879-81. PubMed ID: 4029915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
